- 10 May 2021
- journal article
- editorial
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 28 (5) , 404-408
Abstract
Structural biology plays a crucial role in the fight against COVID-19, permitting us to ‘see’ and understand SARS-CoV-2. However, the macromolecular structures of SARS-CoV-2 proteins that were solved with great speed and urgency can contain errors that may hinder drug design. The Coronavirus Structural Task Force has been working behind the scenes to evaluate and improve these structures, making the results freely available at https://insidecorona.net/.Keywords
All Related Versions
This publication has 23 references indexed in Scilit:
- Recent developments in theCCP-EMsoftware suiteActa Crystallographica Section D Structural Biology, 2017
- A public database of macromolecular diffraction experimentsActa Crystallographica Section D Structural Biology, 2016
- Refinement of atomic models in high resolution EM reconstructions using Flex-EM and local assessmentMethods, 2016
- EMPIAR: a public archive for raw electron microscopy image dataNature Methods, 2016
- Privateer: software for the conformational validation of carbohydrate structuresNature Structural & Molecular Biology, 2015
- ThePDB_REDOserver for macromolecular structure model optimizationIUCrJ, 2014
- Collaboration gets the most out of softwareeLife, 2013
- Proteopedia: A status report on the collaborative, 3D web-encyclopedia of proteins and other biomoleculesJournal of Structural Biology, 2011
- EMDataBank.org: unified data resource for CryoEMNucleic Acids Research, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010